The findings of Valenstein and colleagues in this issue do not imply that detecting depression is unimportant. Instead, the authors' cost-utility analysis raises questions about universal screening (as opposed to selective case finding) and about merely improving detection without simultaneously enhancing treatment and follow-up.
|Original language||English (US)|
|Number of pages||3|
|Journal||Annals of internal medicine|
|State||Published - Mar 6 2001|
ASJC Scopus subject areas
- Internal Medicine